(Q37557634)

21 August 2017

1 reference

title

Cell death pathways--potential therapeutic targets (English)

1 reference

21 August 2017

1 reference

M MacFarlane

1

1 reference

PubMed ID

19622004

21 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

21 August 2017

1 reference

21 August 2017

39

1 reference

21 August 2017

8

1 reference

21 August 2017

616-624

1 reference

Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ

21 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

To kill a tumor cell: the potential of proapoptotic receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

How death shapes life during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

The Apaf-1 apoptosome: a large caspase-activating complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Caspases: the executioners of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Cell death: critical control points

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

X-linked IAP is a direct inhibitor of cell-death proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Promoting apoptosis as a strategy for cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

To die or not to die: that is the autophagic question

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Cell death by necrosis: towards a molecular definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

The TRAIL apoptotic pathway in cancer onset, progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

TRAIL-induced signalling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Processing/activation of at least four interleukin-1beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Apoptosis and disease: a life or death decision

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

The CD95(APO-1/Fas) DISC and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Structural biology of the Bcl-2 family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

The inhibitor of apoptosis proteins as therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

Smac mimetics and TNFalpha: a dangerous liaison?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

The BCL-2 protein family: opposing activities that mediate cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250903137990

10.1080/00498250903137990

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19622004